i'm pretty excited about this LV analysis - I summarized the previous 3 RMDs to describe which of the 98 RF-selected LVs correlated with immune subtypes, metaviper activity, or have significantly changing genomic variants.
@allaway if you want to add some drug-target analysis, a summary should go in this table before we describe it in the manuscript.
i'm pretty excited about this LV analysis - I summarized the previous 3 RMDs to describe which of the 98 RF-selected LVs correlated with immune subtypes, metaviper activity, or have significantly changing genomic variants.
@allaway if you want to add some drug-target analysis, a summary should go in this table before we describe it in the manuscript.